CRC researchers stood out in the highly competitive CIHR Project Grant competition in Fall 2024. Nine proposals were selected, securing more than $8 million in funding for our teams.
These grants will provide our researchers with the opportunity to further their work and explore innovative approaches with significant impact in their respective fields.
Here is an overview of the selected projects:
Lynn Gauthier: MI SENS-OR REHAB: Feasibility, acceptability, and preliminary effects of a novel, multimodal, Motivational Interviewing-guided somatoSENSory - motOR REHABilitation intervention for chemotherapy-induced peripheral neuropathy
Yohan Bossé: The lung molecular and cellular transition to adenocarcinoma
Nicolas Bisson: Deciphering how oncogenic tyrosine kinase receptors rewire cell signaling networks via SRC-Homology (SH) 3 domain phosphorylation
Stéphane Bolduc: Urethral reconstruction using tissue engineering, final steps towards clinical translation
Yannick Doyon: In vivo genome editing for inborn errors of metabolism.
Humphrey Fonge et Maruti Uppalapati: 161Tb/225Ac-labeled anti-Nectin-4 radioimmunoconjugates with/without immune checkpoint inhibitors against NSCLC
Jean-Philippe Lambert et Philippe Roux: Regulation of BRD2 phosphorylation and Its role in melanoma progression
Mathieu Laplante: Exploring the biology of HSDL2 in health and disease
Jean-Yves Masson (in collaboration with Guy Poirier): Defining and targeting the eraser functions of Poly(ADP-ribose) Glycohydrolase (PARG) in PAR-DNA hybrids and DNA double-strand break repair
Congratulations to all!